Ignite Creation Date:
2024-05-06 @ 4:21 PM
Last Modification Date:
2024-10-26 @ 2:08 PM
Study NCT ID:
NCT04950504
Status:
TERMINATED
Last Update Posted:
2023-09-18
First Post:
2021-06-03
Brief Title:
Evaluate the Safety Tolerability Pharmacodynamics and Efficacy of CNP-201 in Subjects Ages 16-35 With Peanut Allergy
Sponsor:
COUR Pharmaceutical Development Company Inc
Organization:
COUR Pharmaceutical Development Company Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-06-02
Start Date Type:
ACTUAL
Primary Completion Date:
2022-06-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-07-29
Completion Date Type:
ACTUAL
First Submit Date:
2021-06-03
First Submit QC Date:
June 23 2021
Study First Post Date:
2021-07-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-09-14
Last Update Post Date:
2023-09-18
Last Update Post Date Type:
ACTUAL